Pear Therapeutics exploring sale, other ‘strategic alternatives’
Without a transaction, the prescription digital therapeutics company said it may need to reorganize or liquidate.
Without a transaction, the prescription digital therapeutics company said it may need to reorganize or liquidate.
Go to Source
2023-03-18 00:20
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
